YM-101 + artificial tear

YM-101 + artificial tear is an investigational combination therapy being developed by the Eye & ENT Hospital of Fudan University for the treatment of dry eye syndrome. The regimen involves the twice-daily administration of YM-101 eye drops in conjunction with the three-times-daily application of artificial tears. This combination is currently being evaluated in a Phase 1, single-center, randomized, double-blind, placebo-controlled, cross-over clinical trial (NCT05484128) to assess its safety and effectiveness in adult patients. While the specific mechanism of action for YM-101 has not been disclosed, the trial aims to determine its therapeutic potential in improving symptoms and clinical signs of dry eye syndrome.